Osteosarcoma: Clinical Trials

23 trials for Osteosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 terminated. 23 Phase 1, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 123Terminated 23
Phase 28Terminated 8

Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
LN-145/LN-144 - Soft Tissue Sarcoma, Primary Central Nervous System Carcinoma
Phase 1TerminatedIovance Biotherapeutics, Inc.52024-03-282026-10-16
TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors
1200mg of TQB2928 injection+Anlotinib, 1800mg of TQB2928 injection+Anlotinib - Osteosarcoma, Other Solid Tumors
Phase 1TerminatedChia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.202024-02-152025-12-12
A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours
[225]-FPI-2059, [111In]-FPI-2058 - Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck
Phase 1Terminated3B Pharmaceuticals GmbH192023-02-072025-08-24
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - High Risk Neuroblastoma, Recurrent Neuroblastoma
Phase 1TerminatedNational Cancer Institute (NCI)122021-08-312026-06-30
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer
Nivolumab, NKTR-214 - Ependymoma, Ewing Sarcoma
Phase 1 / Phase 2TerminatedBristol-Myers Squibb152021-06-032023-03-24
IBI188 Combination Therapy in Solid Tumors
IBI188, GM-CSF, Cisplatin/Carboplatin - Solid Tumors, Lung Adenocarcinoma
Phase 1TerminatedInnovent Biologics (Suzhou) Co. Ltd.92021-05-252022-10-04
Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
Niraparib (Tablet for oral suspension), Dostarlimab, Niraparib (Tablet) - Neoplasms
Phase 1TerminatedGlaxoSmithKline472020-10-062026-01-21
Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers
Humanized 3F8 Bispecific Antibody, Blood draw - Neuroblastoma, Osteosarcoma
Phase 1 / Phase 2TerminatedY-mAbs Therapeutics122019-02-222023-09-13
Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors
TP-1287 - Advanced Solid Tumors, Sarcoma
Phase 1TerminatedSumitomo Pharma America, Inc.742018-12-262024-09-19
A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma
INCB059872 - Relapsed Ewing Sarcoma
Phase 1TerminatedIncyte Corporation252018-06-272025-10-21
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
Copanlisib (BAY806946) - Relapsed or Refractory Solid Tumors or Lymphoma in Children, Neuroblastoma
Phase 1 / Phase 2TerminatedBayer312018-04-302023-12-04
Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
CB-103 - Breast Cancer, Colorectal Cancer
Phase 1 / Phase 2TerminatedCellestia Biotech AG792017-12-052024-01-16
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Stereotactic Body Radiotherapy (SBRT) - Ewing Sarcoma, Rhabdomyosarcoma
Phase 1 / Phase 2TerminatedDana-Farber Cancer Institute52017-01-012021-04-30
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
Magnetic resonance high intensity focused ultrasound, Lyso-thermosensitive liposomal doxorubicin - Pediatric Cancer, Solid Tumors
Phase 1TerminatedAeRang Kim22016-10-012023-08-29
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
TK216 - Sarcoma, Ewing
Phase 1 / Phase 2TerminatedOncternal Therapeutics, Inc852016-08-012025-02-12
Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma
Mithramycin - Ewing Sarcoma, Sarcoma
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)82012-05-102018-03-02
Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
Eltrombopag - Sarcoma, Soft Tissue, Osteosarcoma
Phase 1TerminatedDuke University12012-04-012014-04-02
A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response
Dexrazoxane, Doxorubicin, Cisplatin - Osteosarcoma, Lung Metastases
Phase 1TerminatedUniversity of Chicago22010-07-012013-12-10
Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
Temsirolimus, Valproic Acid - Brain and Central Nervous System Tumors, Neuroblastoma
Phase 1TerminatedUNC Lineberger Comprehensive Cancer Center72009-11-012016-12-23
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
carboplatin, dasatinib, etoposide phosphate - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
Phase 1 / Phase 2TerminatedCity of Hope Medical Center72008-09-102026-11-04

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Sarcoma, Ewing (12)  ·  Neuroblastoma (11)  ·  Sarcoma (10)  ·  Rhabdomyosarcoma (8)  ·  Neoplasms (5)  ·  Neuroectodermal Tumors, Primitive, Peripheral (5)  ·  Central Nervous System Neoplasms (4)  ·  Medulloblastoma (4)  ·  Wilms Tumor (4)  ·  Lymphoma (3)  ·  Neoplasm Metastasis (3)  ·  Recurrence (3)  ·  Rhabdoid Tumor (3)  ·  Astrocytoma (2)

Broader conditions

Neoplasms by Histologic Type (23)  ·  Neoplasms, Bone Tissue (23)  ·  Neoplasms, Connective Tissue (23)  ·  Neoplasms, Connective and Soft Tissue (22)  ·  Neoplasms (18)  ·  Neoplasms, Glandular and Epithelial (15)  ·  Neoplasms by Site (13)  ·  Neoplasms, Nerve Tissue (13)  ·  Sarcoma (13)  ·  Neoplasms, Germ Cell and Embryonal (12)  ·  Neoplasms, Neuroepithelial (12)  ·  Neuroectodermal Tumors (12)  ·  Neuroectodermal Tumors, Primitive (12)  ·  Myosarcoma (8)  ·  Neoplasms, Muscle Tissue (8)

Interventions

Carboplatin (2)  ·  Cisplatin (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Ifosfamide (2)  ·  Amifostine (1)  ·  Bevacizumab (1)  ·  Biopsy (1)  ·  Blood Specimen Collection (1)  ·  Blotting, Western (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Dasatinib (1)  ·  Dexrazoxane (1)  ·  Doxorubicin (1)  ·  Etoposide (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  Y-mAbs Therapeutics (2)  ·  3B Pharmaceuticals GmbH (1)  ·  AeRang Kim (1)  ·  Bayer (1)  ·  Bristol-Myers Squibb (1)  ·  Cellestia Biotech AG (1)  ·  Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. (1)  ·  City of Hope Medical Center (1)  ·  Dana-Farber Cancer Institute (1)  ·  Duke University (1)  ·  GlaxoSmithKline (1)  ·  Incyte Corporation (1)  ·  Innovent Biologics (Suzhou) Co. Ltd. (1)  ·  Iovance Biotherapeutics, Inc. (1)

Countries

United States (20)  ·  Spain (3)  ·  Australia (2)  ·  China (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  United Kingdom (2)  ·  Canada (1)  ·  South Korea (1)  ·  Switzerland (1)

Top investigators

Aaron Enke (1)  ·  AeRang Kim, MD, PhD (1)  ·  Andres Morales, MD (1)  ·  Ba Yi (1)  ·  Brigitte C Widemann, M.D. (1)  ·  Crystal L Mackall, M.D. (1)  ·  Elena Garalda, MD, PhD (1)  ·  Fang Meiyu (1)  ·  Fred Zheng, MD (1)  ·  Guo Hongqian (1)  ·  Guo Wei (1)  ·  James Breitmeyer, MD (1)

Results publications

PMID 31401903, PMID 23071222, PMID 28735378, PMID 33047248, PMID 33305087, PMID 36371226, PMID 38954782, PMID 39563886

NIH funding

2017 (1), 2018 (1), P30CA015704 (1), P30CA016086 (1), P30CA033572 (1), U01CA154967 (1), UM1CA228823 (1)